{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:56:00Z","timestamp":1790286960070,"version":"4.1.0"},"reference-count":179,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T00:00:00Z","timestamp":1490054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T00:00:00Z","timestamp":1490054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1038\/mp.2017.36","type":"journal-article","created":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T09:28:19Z","timestamp":1490088499000},"page":"656-665","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":180,"title":["Identifying fast-onset antidepressants using rodent models"],"prefix":"10.1038","volume":"22","author":[{"given":"M J","family":"Ramaker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S C","family":"Dulawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,21]]},"reference":[{"key":"BFmp201736_CR1","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","volume":"289","author":"RC Kessler","year":"2003","unstructured":"Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003; 289: 3095\u20133105.","journal-title":"JAMA"},{"key":"BFmp201736_CR2","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1056\/NEJMoa052964","volume":"354","author":"MH Trivedi","year":"2006","unstructured":"Trivedi MH, Fava M, Wisniewski SR, Thase ME, Quitkin F, Warden D et al. Medication augmentation after the failure of SSRIs for depression. N Engl J Med 2006; 354: 1243\u20131252.","journal-title":"N Engl J Med"},{"key":"BFmp201736_CR3","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.4088\/JCP.v68n0713","volume":"68","author":"D Souery","year":"2007","unstructured":"Souery D, Oswald P, Massat I, Bailer U, Bollen J, Demyttenaere K et al. Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study. J Clin Psychiatry 2007; 68: 1062\u20131070.","journal-title":"J Clin Psychiatry"},{"issue":"Suppl 6","key":"BFmp201736_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4088\/JCP.8133su1c.03","volume":"70","author":"GI Papakostas","year":"2009","unstructured":"Papakostas GI . Managing partial response or nonresponse: switching, augmentation, and combination strategies for major depressive disorder. J Clin Psychiatry 2009; 70 (Suppl 6): 16\u201325.","journal-title":"J Clin Psychiatry"},{"key":"BFmp201736_CR5","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1176\/appi.ajp.2007.06111868","volume":"165","author":"M Fava","year":"2008","unstructured":"Fava M, Rush AJ, Alpert JE, Balasubramani GK, Wisniewski SR, Carmin CN et al. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry 2008; 165: 342\u2013351.","journal-title":"Am J Psychiatry"},{"key":"BFmp201736_CR6","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1177\/0269881112466185","volume":"27","author":"C Hendrie","year":"2013","unstructured":"Hendrie C, Pickles A, Stanford SC, Robinson E . The failure of the antidepressant drug discovery process is systemic. J Psychopharmacol 2013; 27: 407\u2013413, discussion 413\u2013416.","journal-title":"J Psychopharmacol"},{"key":"BFmp201736_CR7","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.euroneuro.2011.05.004","volume":"21","author":"D Nutt","year":"2011","unstructured":"Nutt D, Goodwin G . ECNP Summit on the future of CNS drug research in Europe 2011: report prepared for ECNP by David Nutt and Guy Goodwin. Eur Neuropsychopharmacol 2011; 21: 495\u2013499.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFmp201736_CR8","first-page":"334","volume-title":"The Antidepressant Era","author":"D Healy","year":"1997","unstructured":"Healy D . The Antidepressant Era. Harvard University Press, 1997; 334."},{"key":"BFmp201736_CR9","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery SA, Asberg M . A new depression scale designed to be sensitive to change. Br J Psychiatry J Ment Sci 1979; 134: 382\u2013389.","journal-title":"Br J Psychiatry J Ment Sci"},{"key":"BFmp201736_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M . A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56\u201362.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFmp201736_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/01.jcp.0000155824.59585.46","volume":"25","author":"M Zimmerman","year":"2005","unstructured":"Zimmerman M, Posternak MA, Chelminski I . Is it time to replace the hamilton depression rating scale as the primary outcome measure in treatment studies of depression? J Clin Psychopharmacol 2005; 25: 105\u2013110.","journal-title":"J Clin Psychopharmacol"},{"key":"BFmp201736_CR12","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1600-0447.1981.tb00676.x","volume":"63","author":"P Bech","year":"1981","unstructured":"Bech P, Allerup P, Gram LF, Reisby N, Rosenberg R, Jacobsen O et al. The hamilton depression scale. Acta Psychiatr Scand 1981; 63: 290\u2013299.","journal-title":"Acta Psychiatr Scand"},{"key":"BFmp201736_CR13","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/gps.4104","volume":"29","author":"PR Shiroma","year":"2014","unstructured":"Shiroma PR, Thuras P, Johns B, Lim KO . Emotion recognition processing as early predictor of response to 8-week citalopram treatment in late-life depression. Int J Geriatr Psychiatry 2014; 29: 1132\u20131139.","journal-title":"Int J Geriatr Psychiatry"},{"key":"BFmp201736_CR14","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1176\/appi.ajp.161.7.1256","volume":"161","author":"CJ Harmer","year":"2004","unstructured":"Harmer CJ, Shelley NC, Cowen PJ, Goodwin GM . Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Am J Psychiatry 2004; 161: 1256\u20131263.","journal-title":"Am J Psychiatry"},{"key":"BFmp201736_CR15","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/sj.npp.1300341","volume":"29","author":"MM Katz","year":"2004","unstructured":"Katz MM, Tekell JL, Bowden CL, Brannan S, Houston JP, Berman N et al. Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression. Neuropsychopharmacology 2004; 29: 566\u2013579.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp201736_CR16","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/BF02245860","volume":"119","author":"RH Segman","year":"1995","unstructured":"Segman RH, Shapira B, Gorfine M, Lerer B . Onset and time course of antidepressant action: psychopharmacological implications of a controlled trial of electroconvulsive therapy. Psychopharmacology 1995; 119: 440\u2013448.","journal-title":"Psychopharmacology"},{"key":"BFmp201736_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1176\/ajp.147.1.14","volume":"147","author":"JC Wu","year":"1990","unstructured":"Wu JC, Bunney WE . The biological basis of an antidepressant response to sleep deprivation and relapse: review and hypothesis. Am J Psychiatry 1990; 147: 14\u201321.","journal-title":"Am J Psychiatry"},{"key":"BFmp201736_CR18","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","volume":"63","author":"CA Zarate","year":"2006","unstructured":"Zarate CA, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006; 63: 856\u2013864.","journal-title":"Arch Gen Psychiatry"},{"key":"BFmp201736_CR19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/01.pra.0000462606.17725.93","volume":"21","author":"S Preskorn","year":"2015","unstructured":"Preskorn S, Macaluso M, Mehra DOV, Zammit G, Moskal JR, Burch RM et al. Randomized proof of concept trial of GLYX-13, an N-methyl-D-aspartate receptor glycine site partial agonist, in major depressive disorder nonresponsive to a previous antidepressant agent. J Psychiatr Pract 2015; 21: 140\u2013149.","journal-title":"J Psychiatr Pract"},{"key":"BFmp201736_CR20","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/archpsyc.63.10.1121","volume":"63","author":"ML Furey","year":"2006","unstructured":"Furey ML, Drevets WC . Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial. Arch Gen Psychiatry 2006; 63: 1121\u20131129.","journal-title":"Arch Gen Psychiatry"},{"key":"BFmp201736_CR21","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature17998","volume":"533","author":"P Zanos","year":"2016","unstructured":"Zanos P, Moaddel R, Morris PJ, Georgiou P, Fischell J, Elmer GI et al. NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature 2016; 533: 481\u2013486.","journal-title":"Nature"},{"key":"BFmp201736_CR22","unstructured":"Animal models of psychiatric disorders Geyer MA . Animal models of psychiatric disorders Markou A . Animal models of psychiatric disorders. In: Watson S (ed.). Psychopharmacology: The Fourth Generation of Progress CD-ROM Version 3, Lippincott Williams & Wilkins, 2000. Available at https:\/\/www.acnp.org\/g4\/GN401000076\/CH.html (Accessed on 13 April 2016)."},{"key":"BFmp201736_CR23","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.1083328","volume":"301","author":"L Santarelli","year":"2003","unstructured":"Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003; 301: 805\u2013809.","journal-title":"Science"},{"key":"BFmp201736_CR24","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/sj.npp.1300433","volume":"29","author":"SC Dulawa","year":"2004","unstructured":"Dulawa SC, Holick KA, Gundersen B, Hen R . Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology 2004; 29: 1321\u20131330.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp201736_CR25","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1038\/nn.4429","volume":"19","author":"SE Hyman","year":"2016","unstructured":"Hyman SE . Back to basics: luring industry back into neuroscience. Nat Neurosci 2016; 19: 1383\u20131384.","journal-title":"Nat Neurosci"},{"key":"BFmp201736_CR26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/npp.2008.173","volume":"34","author":"A Markou","year":"2009","unstructured":"Markou A, Chiamulera C, Geyer MA, Tricklebank M, Steckler T . Removing obstacles in neuroscience drug discovery: the future path for animal models. Neuropsychopharmacology 2009; 34: 74\u201389.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp201736_CR27","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.pharmthera.2005.06.012","volume":"108","author":"CW Gorodetzky","year":"2005","unstructured":"Gorodetzky CW, Grudzinskas C . Involving the pharmaceutical and biotech communities in medication development for substance abuse. Pharmacol Ther 2005; 108: 109\u2013118.","journal-title":"Pharmacol Ther"},{"key":"BFmp201736_CR28","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/0031-9384(91)90411-G","volume":"50","author":"JM De Pablo","year":"1991","unstructured":"De Pablo JM, Ortiz-Caro J, Sanchez-Santed F, Guillam\u00f3n A . Effects of diazepam, pentobarbital, scopolamine and the timing of saline injection on learned immobility in rats. Physiol Behav 1991; 50: 895\u2013899.","journal-title":"Physiol Behav"},{"key":"BFmp201736_CR29","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/0014-2999(79)90483-7","volume":"58","author":"RG Browne","year":"1979","unstructured":"Browne RG . Effects of antidepressants and anticholinergics in a mouse \u201cbehavioral despair\u201d test. Eur J Pharmacol 1979; 58: 331\u2013334.","journal-title":"Eur J Pharmacol"},{"key":"BFmp201736_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nature10130","volume":"475","author":"AE Autry","year":"2011","unstructured":"Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, Cheng P et al. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 2011; 475: 91\u201395.","journal-title":"Nature"},{"key":"BFmp201736_CR31","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1126\/science.1190287","volume":"329","author":"N Li","year":"2010","unstructured":"Li N, Lee B, Liu R-J, Banasr M, Dwyer JM, Iwata M et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 2010; 329: 959\u2013964.","journal-title":"Science"},{"key":"BFmp201736_CR32","doi-asserted-by":"crossref","unstructured":"Lu Y, Wang C, Xue Z, Li C, Zhang J, Zhao X et al. PI3K\/AKT\/mTOR signaling-mediated neuropeptide VGF in the hippocampus of mice is involved in the rapid onset antidepressant-like effects of GLYX-13. Int J Neuropsychopharmacol 2015; 18.","DOI":"10.1093\/ijnp\/pyu110"},{"key":"BFmp201736_CR33","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1007\/s00213-016-4399-2","volume":"233","author":"B Yang","year":"2016","unstructured":"Yang B, Zhang J-C, Han M, Yao W, Yang C, Ren Q et al. Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression. Psychopharmacology 2016; 233: 3647\u20133657.","journal-title":"Psychopharmacology"},{"key":"BFmp201736_CR34","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/npp.2012.246","volume":"38","author":"J Burgdorf","year":"2013","unstructured":"Burgdorf J, Zhang X, Nicholson KL, Balster RL, Leander JD, Stanton PK et al. GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects. Neuropsychopharmacology 2013; 38: 729\u2013742.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp201736_CR35","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.biopsych.2013.04.025","volume":"74","author":"B Voleti","year":"2013","unstructured":"Voleti B, Navarria A, Liu R-J, Banasr M, Li N, Terwilliger R et al. Scopolamine rapidly increases mammalian target of rapamycin complex 1 signaling, synaptogenesis, and antidepressant behavioral responses. Biol Psychiatry 2013; 74: 742\u2013749.","journal-title":"Biol Psychiatry"},{"key":"BFmp201736_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ijnp\/pyu033","volume":"18","author":"AE Lepack","year":"2015","unstructured":"Lepack AE, Fuchikami M, Dwyer JM, Banasr M, Duman RS . BDNF release is required for the behavioral actions of ketamine. Int J Neuropsychopharmacol 2015; 18: 1.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFmp201736_CR37","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","volume":"63","author":"S Maeng","year":"2008","unstructured":"Maeng S, Zarate CA, Du J, Schloesser RJ, McCammon J, Chen G et al. Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry 2008; 63: 349\u2013352.","journal-title":"Biol Psychiatry"},{"key":"BFmp201736_CR38","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ejphar.2014.10.063","volume":"753","author":"BJ Caldarone","year":"2015","unstructured":"Caldarone BJ, Zachariou V, King SL . Rodent models of treatment-resistant depression. Eur J Pharmacol 2015; 753: 51\u201365.","journal-title":"Eur J Pharmacol"},{"key":"BFmp201736_CR39","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0163-7258(97)00004-1","volume":"74","author":"JP Kelly","year":"1997","unstructured":"Kelly JP, Wrynn AS, Leonard BE . The olfactory bulbectomized rat as a model of depression: an update. Pharmacol Ther 1997; 74: 299\u2013316.","journal-title":"Pharmacol Ther"},{"key":"BFmp201736_CR40","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neubiorev.2005.03.010","volume":"29","author":"C Song","year":"2005","unstructured":"Song C, Leonard BE . The olfactory bulbectomised rat as a model of depression. Neurosci Biobehav Rev 2005; 29: 627\u2013647.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFmp201736_CR41","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0091-3057(97)00259-1","volume":"58","author":"AM Redmond","year":"1997","unstructured":"Redmond AM, Kelly JP, Leonard BE . Behavioural and neurochemical effects of dizocilpine in the olfactory bulbectomized rat model of depression. Pharmacol Biochem Behav 1997; 58: 355\u2013359.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFmp201736_CR42","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00429-008-0189-x","volume":"213","author":"WC Drevets","year":"2008","unstructured":"Drevets WC, Price JL, Furey ML . Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct 2008; 213: 93\u2013118.","journal-title":"Brain Struct Funct"},{"key":"BFmp201736_CR43","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/sj.mp.4001457","volume":"9","author":"JF Cryan","year":"2004","unstructured":"Cryan JF, Mombereau C . In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry 2004; 9: 326\u2013357.","journal-title":"Mol Psychiatry"},{"issue":"Suppl 1","key":"BFmp201736_CR44","doi-asserted-by":"publisher","first-page":"49S","DOI":"10.1111\/j.1365-2125.1985.tb02742.x","volume":"19","author":"WT O\u2019Connor","year":"1985","unstructured":"O\u2019Connor WT, Earley B, Leonard BE . Antidepressant properties of the triazolobenzodiazepines alprazolam and adinazolam: studies on the olfactory bulbectomized rat model of depression. Br J Clin Pharmacol 1985; 19 (Suppl 1): 49S\u201356S.","journal-title":"Br J Clin Pharmacol"},{"key":"BFmp201736_CR45","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/j.1600-0447.1986.tb06239.x","volume":"74","author":"WT Smith","year":"1986","unstructured":"Smith WT, Glaudin V . Double-blind efficacy and safety study comparing adinazolam mesylate and placebo in depressed inpatients. Acta Psychiatr Scand 1986; 74: 238\u2013245.","journal-title":"Acta Psychiatr Scand"},{"key":"BFmp201736_CR46","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/00004850-199100620-00001","volume":"6","author":"SH Kennedy","year":"1991","unstructured":"Kennedy SH, de Groot J, Ralevski E, Reed K . A comparison of adinazolam and desipramine in the treatment of major depression. Int Clin Psychopharmacol 1991; 6: 65\u201376.","journal-title":"Int Clin Psychopharmacol"},{"key":"BFmp201736_CR47","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1007\/BF00178511","volume":"88","author":"JD Amsterdam","year":"1986","unstructured":"Amsterdam JD, Kaplan M, Potter L, Bloom L, Rickels K . Adinazolam, a new triazolobenzodiazepine, and imipramine in the treatment of major depressive disorder. Psychopharmacology 1986; 88: 484\u2013488.","journal-title":"Psychopharmacology"},{"key":"BFmp201736_CR48","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0165-1781(88)90012-1","volume":"23","author":"F Hicks","year":"1988","unstructured":"Hicks F, Robins E, Murphy GE . Comparison of adinazolam, amitriptyline, and placebo in the treatment of melancholic depression. Psychiatry Res 1988; 23: 221\u2013227.","journal-title":"Psychiatry Res"},{"key":"BFmp201736_CR49","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1177\/070674370705200108","volume":"52","author":"MT Berlim","year":"2007","unstructured":"Berlim MT, Turecki G . Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods. Can J Psychiatry 2007; 52: 46\u201354.","journal-title":"Can J Psychiatry"},{"key":"BFmp201736_CR50","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1007\/s00213-016-4256-3","volume":"233","author":"K Holubova","year":"2016","unstructured":"Holubova K, Kleteckova L, Skurlova M, Ricny J, Stuchlik A, Vales K . Rapamycin blocks the antidepressant effect of ketamine in task-dependent manner. Psychopharmacology 2016; 233: 2077\u20132097.","journal-title":"Psychopharmacology"},{"key":"BFmp201736_CR51","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s12035-014-8721-x","volume":"51","author":"MJ Maturana","year":"2015","unstructured":"Maturana MJ, Pudell C, Targa ADS, Rodrigues LS, Noseda ACD, Fortes MH et al. REM sleep deprivation reverses neurochemical and other depressive-like alterations induced by olfactory bulbectomy. Mol Neurobiol 2015; 51: 349\u2013360.","journal-title":"Mol Neurobiol"},{"key":"BFmp201736_CR52","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0014-2999(98)00402-6","volume":"352","author":"JF Cryan","year":"1998","unstructured":"Cryan JF, McGrath C, Leonard BE, Norman TR . Combining pindolol and paroxetine in an animal model of chronic antidepressant action\u2014can early onset of action be detected? Eur J Pharmacol 1998; 352: 23\u201328.","journal-title":"Eur J Pharmacol"},{"key":"BFmp201736_CR53","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0278-5846(84)80032-9","volume":"8","author":"SF Maier","year":"1984","unstructured":"Maier SF . Learned helplessness and animal models of depression. Prog Neuropsychopharmacol Biol Psychiatry 1984; 8: 435\u2013446.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFmp201736_CR54","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/mp.2013.144","volume":"19","author":"MD Opal","year":"2014","unstructured":"Opal MD, Klenotich SC, Morais M, Bessa J, Winkle J, Doukas D et al. Serotonin 2C receptor antagonists induce fast-onset antidepressant effects. Mol Psychiatry 2014; 19: 1106\u20131114.","journal-title":"Mol Psychiatry"},{"key":"BFmp201736_CR55","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.neuron.2007.07.041","volume":"55","author":"G Lucas","year":"2007","unstructured":"Lucas G, Rymar VV, Du J, Mnie-Filali O, Bisgaard C, Manta S et al. Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action. Neuron 2007; 55: 712\u2013725.","journal-title":"Neuron"},{"key":"BFmp201736_CR56","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1476-5381.1977.tb07530.x","volume":"60","author":"H van Riezen","year":"1977","unstructured":"van Riezen H, Schnieden H, Wren AF . Olfactory bulb ablation in the rat: behavioural changes and their reversal by antidepressant drugs. Br J Pharmacol 1977; 60: 521\u2013528.","journal-title":"Br J Pharmacol"},{"key":"BFmp201736_CR57","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","volume":"47","author":"RD Porsolt","year":"1978","unstructured":"Porsolt RD, Anton G, Blavet N, Jalfre M . Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 1978; 47: 379\u2013391.","journal-title":"Eur J Pharmacol"},{"key":"BFmp201736_CR58","first-page":"327","volume":"229","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Bertin A, Jalfre M . Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977; 229: 327\u2013336.","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"BFmp201736_CR59","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s002130100694","volume":"155","author":"I Lucki","year":"2001","unstructured":"Lucki I, Dalvi A, Mayorga AJ . Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology 2001; 155: 315\u2013322.","journal-title":"Psychopharmacology"},{"key":"BFmp201736_CR60","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00213-010-2140-0","volume":"213","author":"J Jiao","year":"2011","unstructured":"Jiao J, Nitzke AM, Doukas DG, Seiglie MP, Dulawa SC . Antidepressant response to chronic citalopram treatment in eight inbred mouse strains. Psychopharmacology 2011; 213: 509\u2013520.","journal-title":"Psychopharmacology"},{"key":"BFmp201736_CR61","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/sj.npp.1301399","volume":"33","author":"KA Holick","year":"2008","unstructured":"Holick KA, Lee DC, Hen R, Dulawa SC . Behavioral effects of chronic fluoxetine in BALB\/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor. Neuropsychopharmacology 2008; 33: 406\u2013417.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp201736_CR62","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.neuroscience.2012.09.057","volume":"251","author":"P Licznerski","year":"2013","unstructured":"Licznerski P, Duman RS . Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression. Neuroscience 2013; 251: 33\u201350.","journal-title":"Neuroscience"},{"key":"BFmp201736_CR63","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1601-183X.2011.00682.x","volume":"10","author":"A Can","year":"2011","unstructured":"Can A, Blackwell RA, Piantadosi SC, Dao DT, O\u2019Donnell KC, Gould TD . Antidepressant-like responses to lithium in genetically diverse mouse strains. Genes Brain Behav 2011; 10: 434\u2013443.","journal-title":"Genes Brain Behav"},{"key":"BFmp201736_CR64","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.neuropharm.2013.05.014","volume":"73","author":"J-P Guilloux","year":"2013","unstructured":"Guilloux J-P, Mendez-David I, Pehrson A, Guiard BP, Rep\u00e9rant C, Orvo\u00ebn S et al. Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice. Neuropharmacology 2013; 73: 147\u2013159.","journal-title":"Neuropharmacology"},{"key":"BFmp201736_CR65","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.biopsych.2011.07.032","volume":"70","author":"NA Shanahan","year":"2011","unstructured":"Shanahan NA, Velez LP, Masten VL, Dulawa SC . Essential role for orbitofrontal serotonin 1B receptors in obsessive-compulsive disorder-like behavior and serotonin reuptake inhibitor response in mice. Biol Psychiatry 2011; 70: 1039\u20131048.","journal-title":"Biol Psychiatry"},{"key":"BFmp201736_CR66","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0014-2999(87)90648-0","volume":"142","author":"T Nagatani","year":"1987","unstructured":"Nagatani T, Yamamoto T, Sugihara T, Ueki S . The effect of agonists at the GABA-benzodiazepine receptor complex on the duration of immobility of mice in the forced swimming test. Eur J Pharmacol 1987; 142: 17\u201322.","journal-title":"Eur J Pharmacol"},{"key":"BFmp201736_CR67","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.biopsych.2010.12.015","volume":"69","author":"N Li","year":"2011","unstructured":"Li N, Liu R-J, Dwyer JM, Banasr M, Lee B, Son H et al. Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol Psychiatry 2011; 69: 754\u2013761.","journal-title":"Biol Psychiatry"},{"key":"BFmp201736_CR68","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/j.1742-7843.2008.00210.x","volume":"103","author":"LS Garcia","year":"2008","unstructured":"Garcia LS, Comim CM, Valvassori SS, R\u00e9us GZ, Andreazza AC, Stertz L et al. Chronic administration of ketamine elicits antidepressant-like effects in rats without affecting hippocampal brain-derived neurotrophic factor protein levels. Basic Clin Pharmacol Toxicol 2008; 103: 502\u2013506.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"BFmp201736_CR69","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/YCT.0000000000000148","volume":"31","author":"J Chen","year":"2015","unstructured":"Chen J, Peng L-H, Luo J, Liu L, Lv F, Li P et al. Effects of low-dose ketamine combined with propofol on phosphorylation of AMPA receptor GluR1 subunit and GABAA receptor in hippocampus of stressed rats receiving electroconvulsive shock. J ECT 2015; 31: 50\u201356.","journal-title":"J ECT"},{"key":"BFmp201736_CR70","first-page":"586","volume":"8","author":"Y Jiang","year":"2015","unstructured":"Jiang Y, Zhu J . Effects of sleep deprivation on behaviors and abnormal hippocampal BDNF\/miR-10B expression in rats with chronic stress depression. Int J Clin Exp Pathol 2015; 8: 586\u2013593.","journal-title":"Int J Clin Exp Pathol"},{"key":"BFmp201736_CR71","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ejphar.2005.03.029","volume":"514","author":"I Yalcin","year":"2005","unstructured":"Yalcin I, Aksu F, Belzung C . Effects of desipramine and tramadol in a chronic mild stress model in mice are altered by yohimbine but not by pindolol. Eur J Pharmacol 2005; 514: 165\u2013174.","journal-title":"Eur J Pharmacol"},{"key":"BFmp201736_CR72","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1038\/sj.npp.1301386","volume":"32","author":"L-M Wu","year":"2007","unstructured":"Wu L-M, Han H, Wang Q-N, Hou H-L, Tong H, Yan X-B et al. Mifepristone repairs region-dependent alteration of synapsin I in hippocampus in rat model of depression. Neuropsychopharmacology 2007; 32: 2500\u20132510.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp201736_CR73","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/npp.2011.319","volume":"37","author":"J-D Sun","year":"2012","unstructured":"Sun J-D, Liu Y, Yuan Y-H, Li J, Chen N-H . Gap junction dysfunction in the prefrontal cortex induces depressive-like behaviors in rats. Neuropsychopharmacology 2012; 37: 1305\u20131320.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp201736_CR74","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0031-9384(97)00042-5","volume":"62","author":"PS D\u2019Aquila","year":"1997","unstructured":"D\u2019Aquila PS, Newton J, Willner P . Diurnal variation in the effect of chronic mild stress on sucrose intake and preference. Physiol Behav 1997; 62: 421\u2013426.","journal-title":"Physiol Behav"},{"key":"BFmp201736_CR75","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/S0031-9384(96)00305-8","volume":"60","author":"NF Forbes","year":"1996","unstructured":"Forbes NF, Stewart CA, Matthews K, Reid IC . Chronic mild stress and sucrose consumption: validity as a model of depression. Physiol Behav 1996; 60: 1481\u20131484.","journal-title":"Physiol Behav"},{"key":"BFmp201736_CR76","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.neubiorev.2005.03.017","volume":"29","author":"SC Dulawa","year":"2005","unstructured":"Dulawa SC, Hen R . Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test. Neurosci Biobehav Rev 2005; 29: 771\u2013783.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFmp201736_CR77","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/BF00442264","volume":"97","author":"SR Bodnoff","year":"1989","unstructured":"Bodnoff SR, Suranyi-Cadotte B, Quirion R, Meaney MJ . A comparison of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxiety. Psychopharmacology 1989; 97: 277\u2013279.","journal-title":"Psychopharmacology"},{"key":"BFmp201736_CR78","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/BF00181937","volume":"95","author":"SR Bodnoff","year":"1988","unstructured":"Bodnoff SR, Suranyi-Cadotte B, Aitken DH, Quirion R, Meaney MJ . The effects of chronic antidepressant treatment in an animal model of anxiety. Psychopharmacology 1988; 95: 298\u2013302.","journal-title":"Psychopharmacology"},{"key":"BFmp201736_CR79","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neuropharm.2012.12.009","volume":"70","author":"N Carrier","year":"2013","unstructured":"Carrier N, Kabbaj M . Sex differences in the antidepressant-like effects of ketamine. Neuropharmacology 2013; 70: 27\u201334.","journal-title":"Neuropharmacology"},{"key":"BFmp201736_CR80","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.neuropharm.2011.08.034","volume":"61","author":"H Koike","year":"2011","unstructured":"Koike H, Iijima M, Chaki S . Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists. Neuropharmacology 2011; 61: 1419\u20131423.","journal-title":"Neuropharmacology"},{"key":"BFmp201736_CR81","doi-asserted-by":"publisher","first-page":"8649","DOI":"10.1073\/pnas.1323920111","volume":"111","author":"ES Gideons","year":"2014","unstructured":"Gideons ES, Kavalali ET, Monteggia LM . Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses. Proc Natl Acad Sci USA 2014; 111: 8649\u20138654.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp201736_CR82","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.bbr.2012.08.016","volume":"235","author":"M Iijima","year":"2012","unstructured":"Iijima M, Fukumoto K, Chaki S . Acute and sustained effects of a metabotropic glutamate 5 receptor antagonist in the novelty-suppressed feeding test. Behav Brain Res 2012; 235: 287\u2013292.","journal-title":"Behav Brain Res"},{"key":"BFmp201736_CR83","doi-asserted-by":"publisher","first-page":"e1000355","DOI":"10.1371\/journal.pbio.1000355","volume":"8","author":"J Mazella","year":"2010","unstructured":"Mazella J, P\u00e9trault O, Lucas G, Deval E, B\u00e9raud-Dufour S, Gandin C et al. Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design. PLoS Biol 2010; 8: e1000355.","journal-title":"PLoS Biol"},{"key":"BFmp201736_CR84","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1017\/S1461145711000782","volume":"15","author":"J Pascual-Brazo","year":"2012","unstructured":"Pascual-Brazo J, Castro E, D\u00edaz A, Valdiz\u00e1n EM, Pilar-Cu\u00e9llar F, Vidal R et al. Modulation of neuroplasticity pathways and antidepressant-like behavioural responses following the short-term (3 and 7 days) administration of the 5-HT4 receptor agonist RS67333. Int J Neuropsychopharmacol 2012; 15: 631\u2013643.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFmp201736_CR85","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1124\/jpet.115.225664","volume":"355","author":"P Zanos","year":"2015","unstructured":"Zanos P, Piantadosi SC, Wu H-Q, Pribut HJ, Dell MJ, Can A et al. The prodrug 4-chlorokynurenine causes ketamine-like antidepressant effects, but not side effects, by NMDA\/glycineb-site inhibition. J Pharmacol Exp Ther 2015; 355: 76\u201385.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFmp201736_CR86","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jphs.2014.09.003","volume":"127","author":"K Fukumoto","year":"2015","unstructured":"Fukumoto K, Chaki S . Involvement of serotonergic system in the effect of a metabotropic glutamate 5 receptor antagonist in the novelty-suppressed feeding test. J Pharmacol Sci 2015; 127: 57\u201361.","journal-title":"J Pharmacol Sci"},{"key":"BFmp201736_CR87","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1007\/s00213-013-3378-0","volume":"231","author":"K Fukumoto","year":"2014","unstructured":"Fukumoto K, Iijima M, Chaki S . Serotonin-1A receptor stimulation mediates effects of a metabotropic glutamate 2\/3 receptor antagonist, 2S-2-amino-2-(1S,2S-2-carboxycycloprop-1-yl)-3-(xanth-9-yl)propanoic acid (LY341495), and an N-methyl-D-aspartate receptor antagonist, ketamine, in the novelty-suppressed feeding test. Psychopharmacology 2014; 231: 2291\u20132298.","journal-title":"Psychopharmacology"},{"key":"BFmp201736_CR88","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbr.2012.10.023","volume":"238","author":"H Koike","year":"2013","unstructured":"Koike H, Fukumoto K, Iijima M, Chaki S . Role of BDNF\/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression. Behav Brain Res 2013; 238: 48\u201352.","journal-title":"Behav Brain Res"},{"key":"BFmp201736_CR89","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/j.euroneuro.2015.07.007","volume":"25","author":"TL Stan","year":"2015","unstructured":"Stan TL, Sousa VC, Zhang X, Ono M, Svenningsson P . Lurasidone and fluoxetine reduce novelty-induced hypophagia and NMDA receptor subunit and PSD-95 expression in mouse brain. Eur Neuropsychopharmacol 2015; 25: 1714\u20131722.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFmp201736_CR90","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00213-007-0945-2","volume":"195","author":"R-M Karlsson","year":"2008","unstructured":"Karlsson R-M, Choe JS, Cameron HA, Thorsell A, Crawley JN, Holmes A et al. The neuropeptide Y Y1 receptor subtype is necessary for the anxiolytic-like effects of neuropeptide Y, but not the antidepressant-like effects of fluoxetine, in mice. Psychopharmacology 2008; 195: 547\u2013557.","journal-title":"Psychopharmacology"},{"key":"BFmp201736_CR91","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.brainres.2015.01.001","volume":"1601","author":"JT Andreasen","year":"2015","unstructured":"Andreasen JT, Fitzpatrick CM, Larsen M, Skovgaard L, Nielsen SD, Clausen RP et al. Differential role of AMPA receptors in mouse tests of antidepressant and anxiolytic action. Brain Res 2015; 1601: 117\u2013126.","journal-title":"Brain Res"},{"key":"BFmp201736_CR92","doi-asserted-by":"publisher","first-page":"e331","DOI":"10.1038\/tp.2013.103","volume":"3","author":"KM Louderback","year":"2013","unstructured":"Louderback KM, Wills TA, Muglia LJ, Winder DG . Knockdown of BNST GluN2B-containing NMDA receptors mimics the actions of ketamine on novelty-induced hypophagia. Transl Psychiatry 2013; 3: e331.","journal-title":"Transl Psychiatry"},{"key":"BFmp201736_CR93","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1126\/science.1120972","volume":"311","author":"O Berton","year":"2006","unstructured":"Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 2006; 311: 864\u2013868.","journal-title":"Science"},{"key":"BFmp201736_CR94","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.biopsych.2015.04.022","volume":"79","author":"RA Brachman","year":"2015","unstructured":"Brachman RA, McGowan JC, Perusini JN, Lim SC, Pham TH, Faye C et al. Ketamine as a prophylactic against stress-induced depressive-like behavior. Biol Psychiatry 2015; 79: 776\u2013786.","journal-title":"Biol Psychiatry"},{"key":"BFmp201736_CR95","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.biopsych.2013.12.014","volume":"76","author":"RJ Donahue","year":"2014","unstructured":"Donahue RJ, Muschamp JW, Russo SJ, Nestler EJ, Carlezon WA . Effects of striatal \u0394FosB overexpression and ketamine on social defeat stress-induced anhedonia in mice. Biol Psychiatry 2014; 76: 550\u2013558.","journal-title":"Biol Psychiatry"},{"key":"BFmp201736_CR96","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/aps.2015.111","volume":"37","author":"Q Zhang","year":"2016","unstructured":"Zhang Q, Guo F, Fu Z-W, Zhang B, Huang C-G, Li Y . Timosaponin derivative YY-23 acts as a non-competitive NMDA receptor antagonist and exerts a rapid antidepressant-like effect in mice. Acta Pharmacol Sin 2016; 37: 166\u2013176.","journal-title":"Acta Pharmacol Sin"},{"key":"BFmp201736_CR97","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/BF02244056","volume":"101","author":"M Geoffroy","year":"1990","unstructured":"Geoffroy M, Scheel-Kr\u00fcger J, Christensen AV . Effect of imipramine in the \u201clearned helplessness\u201d model of depression in rats is not mimicked by combinations of specific reuptake inhibitors and scopolamine. Psychopharmacology 1990; 101: 371\u2013375.","journal-title":"Psychopharmacology"},{"key":"BFmp201736_CR98","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/mp.2011.47","volume":"16","author":"E Beurel","year":"2011","unstructured":"Beurel E, Song L, Jope RS . Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice. Mol Psychiatry 2011; 16: 1068\u20131070.","journal-title":"Mol Psychiatry"},{"key":"BFmp201736_CR99","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3109\/15622975.2011.580778","volume":"13","author":"S Biedermann","year":"2012","unstructured":"Biedermann S, Weber-Fahr W, Zheng L, Hoyer C, Vollmayr B, Gass P et al. Increase of hippocampal glutamate after electroconvulsive treatment: a quantitative proton MR spectroscopy study at 9.4\u2009T in an animal model of depression. World J Biol Psychiatry 2012; 13: 447\u2013457.","journal-title":"World J Biol Psychiatry"},{"key":"BFmp201736_CR100","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1097\/00001756-200312020-00013","volume":"14","author":"A Sartorius","year":"2003","unstructured":"Sartorius A, Vollmayr B, Neumann-Haefelin C, Ende G, Hoehn M, Henn FA . Specific creatine rise in learned helplessness induced by electroconvulsive shock treatment. Neuroreport 2003; 14: 2199\u20132201.","journal-title":"Neuroreport"},{"key":"BFmp201736_CR101","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/0091-3057(82)90451-8","volume":"16","author":"AD Sherman","year":"1982","unstructured":"Sherman AD, Sacquitne JL, Petty F . Specificity of the learned helplessness model of depression. Pharmacol Biochem Behav 1982; 16: 449\u2013454.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFmp201736_CR102","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","volume":"29","author":"JF Cryan","year":"2005","unstructured":"Cryan JF, Mombereau C, Vassout A . The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 2005; 29: 571\u2013625.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFmp201736_CR103","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/00008877-199711000-00010","volume":"8","author":"I Lucki","year":"1997","unstructured":"Lucki I . The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav Pharmacol 1997; 8: 523\u2013532.","journal-title":"Behav Pharmacol"},{"key":"BFmp201736_CR104","doi-asserted-by":"publisher","first-page":"7539","DOI":"10.1523\/JNEUROSCI.15-11-07539.1995","volume":"15","author":"M Nibuya","year":"1995","unstructured":"Nibuya M, Morinobu S, Duman RS . Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 1995; 15: 7539\u20137547.","journal-title":"J Neurosci"},{"key":"BFmp201736_CR105","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1126\/science.270.5236.593","volume":"270","author":"H Thoenen","year":"1995","unstructured":"Thoenen H . Neurotrophins and neuronal plasticity. Science 1995; 270: 593\u2013598.","journal-title":"Science"},{"key":"BFmp201736_CR106","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1186\/1472-6882-14-338","volume":"14","author":"B Lee","year":"2014","unstructured":"Lee B, Sur B, Shim J, Hahm D-H, Lee H . Acupuncture stimulation improves scopolamine-induced cognitive impairment via activation of cholinergic system and regulation of BDNF and CREB expressions in rats. BMC Complement Altern Med 2014; 14: 338.","journal-title":"BMC Complement Altern Med"},{"key":"BFmp201736_CR107","doi-asserted-by":"publisher","first-page":"e27265","DOI":"10.1371\/journal.pone.0027265","volume":"6","author":"A Konar","year":"2011","unstructured":"Konar A, Shah N, Singh R, Saxena N, Kaul SC, Wadhwa R et al. Protective role of Ashwagandha leaf extract and its component withanone on scopolamine-induced changes in the brain and brain-derived cells. PloS ONE 2011; 6: e27265.","journal-title":"PloS ONE"},{"key":"BFmp201736_CR108","doi-asserted-by":"publisher","first-page":"e88076","DOI":"10.1371\/journal.pone.0088076","volume":"9","author":"W Chen","year":"2014","unstructured":"Chen W, Cheng X, Chen J, Yi X, Nie D, Sun X et al. Lycium barbarum polysaccharides prevent memory and neurogenesis impairments in scopolamine-treated rats. PloS ONE 2014; 9: e88076.","journal-title":"PloS ONE"},{"key":"BFmp201736_CR109","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.cbi.2008.04.004","volume":"175","author":"S Kotani","year":"2008","unstructured":"Kotani S, Yamauchi T, Teramoto T, Ogura H . Donepezil, an acetylcholinesterase inhibitor, enhances adult hippocampal neurogenesis. Chem Biol Interact 2008; 175: 227\u2013230.","journal-title":"Chem Biol Interact"},{"key":"BFmp201736_CR110","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00213-013-3149-y","volume":"230","author":"Z Shi","year":"2013","unstructured":"Shi Z, Chen L, Li S, Chen S, Sun X, Sun L et al. Chronic scopolamine-injection-induced cognitive deficit on reward-directed instrumental learning in rat is associated with CREB signaling activity in the cerebral cortex and dorsal hippocampus. Psychopharmacology 2013; 230: 245\u2013260.","journal-title":"Psychopharmacology"},{"key":"BFmp201736_CR111","doi-asserted-by":"publisher","first-page":"155","DOI":"10.12965\/jer.140110","volume":"10","author":"Y-M Heo","year":"2014","unstructured":"Heo Y-M, Shin M-S, Kim S-H, Kim T-W, Baek S-B, Baek S-S . Treadmill exercise ameliorates disturbance of spatial learning ability in scopolamine-induced amnesia rats. J Exerc Rehabil 2014; 10: 155\u2013161.","journal-title":"J Exerc Rehabil"},{"key":"BFmp201736_CR112","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.1523\/JNEUROSCI.20-11-04030.2000","volume":"20","author":"J Thome","year":"2000","unstructured":"Thome J, Sakai N, Shin K, Steffen C, Zhang YJ, Impey S et al. cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J Neurosci 2000; 20: 4030\u20134036.","journal-title":"J Neurosci"},{"key":"BFmp201736_CR113","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0306-4522(98)00289-9","volume":"89","author":"VA Vaidya","year":"1999","unstructured":"Vaidya VA, Siuciak JA, Du F, Duman RS . Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures. Neuroscience 1999; 89: 157\u2013166.","journal-title":"Neuroscience"},{"key":"BFmp201736_CR114","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/syn.21779","volume":"69","author":"E Acosta-Pe\u00f1a","year":"2015","unstructured":"Acosta-Pe\u00f1a E, Camacho-Abrego I, Melgarejo-Guti\u00e9rrez M, Flores G, Drucker-Col\u00edn R, Garc\u00eda-Garc\u00eda F . Sleep deprivation induces differential morphological changes in the hippocampus and prefrontal cortex in young and old rats. Synapse 2015; 69: 15\u201325.","journal-title":"Synapse"},{"key":"BFmp201736_CR115","doi-asserted-by":"publisher","first-page":"13573","DOI":"10.1038\/srep13573","volume":"5","author":"J Tang","year":"2015","unstructured":"Tang J, Xue W, Xia B, Ren L, Tao W, Chen C et al. Involvement of normalized NMDA receptor and mTOR-related signaling in rapid antidepressant effects of Yueju and ketamine on chronically stressed mice. Sci Rep 2015; 5: 13573.","journal-title":"Sci Rep"},{"key":"BFmp201736_CR116","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1017\/S1461145710000544","volume":"13","author":"F Fumagalli","year":"2010","unstructured":"Fumagalli F, Pasini M, Sartorius A, Scherer R, Racagni G, Riva MA et al. Repeated electroconvulsive shock (ECS) alters the phosphorylation of glutamate receptor subunits in the rat hippocampus. Int J Neuropsychopharmacol 2010; 13: 1255\u20131260.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFmp201736_CR117","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.psychres.2016.07.020","volume":"243","author":"X Gao","year":"2016","unstructured":"Gao X, Zhuang F-Z, Qin S-J, Zhou L, Wang Y, Shen Q-F et al. Dexmedetomidine protects against learning and memory impairments caused by electroconvulsive shock in depressed rats: involvement of the NMDA receptor subunit 2B (NR2B)-ERK signaling pathway. Psychiatry Res 2016; 243: 446\u2013452.","journal-title":"Psychiatry Res"},{"key":"BFmp201736_CR118","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.bbr.2015.10.002","volume":"300","author":"M Xie","year":"2016","unstructured":"Xie M, Li C, He C, Yang L, Tan G, Yan J et al. Short-term sleep deprivation disrupts the molecular composition of ionotropic glutamate receptors in entorhinal cortex and impairs the rat spatial reference memory. Behav Brain Res 2016; 300: 70\u201376.","journal-title":"Behav Brain Res"},{"key":"BFmp201736_CR119","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.bbr.2015.02.040","volume":"286","author":"M Xie","year":"2015","unstructured":"Xie M, Yan J, He C, Yang L, Tan G, Li C et al. Short-term sleep deprivation impairs spatial working memory and modulates expression levels of ionotropic glutamate receptor subunits in hippocampus. Behav Brain Res 2015; 286: 64\u201370.","journal-title":"Behav Brain Res"},{"key":"BFmp201736_CR120","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000356517","volume":"21","author":"W Zhou","year":"2014","unstructured":"Zhou W, Dong L, Wang N, Shi J, Yang J, Zuo Z et al. Akt mediates GSK-3\u03b2 phosphorylation in the rat prefrontal cortex during the process of ketamine exerting rapid antidepressant actions. Neuroimmunomodulation 2014; 21: 183\u2013188.","journal-title":"Neuroimmunomodulation"},{"key":"BFmp201736_CR121","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1017\/S1461145710000489","volume":"14","author":"CHK West","year":"2011","unstructured":"West CHK, Weiss JM . Effects of chronic antidepressant drug administration and electroconvulsive shock on activity of dopaminergic neurons in the ventral tegmentum. Int J Neuropsychopharmacol 2011; 14: 201\u2013210.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFmp201736_CR122","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/syn.21685","volume":"67","author":"P Tsen","year":"2013","unstructured":"Tsen P, El Mansari M, Blier P . Effects of repeated electroconvulsive shocks on catecholamine systems: electrophysiological studies in the rat brain. Synape 2013; 67: 716\u2013727.","journal-title":"Synape"},{"key":"BFmp201736_CR123","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.biopsych.2014.04.014","volume":"76","author":"P Belujon","year":"2014","unstructured":"Belujon P, Grace AA . Restoring mood balance in depression: ketamine reverses deficit in dopamine-dependent synaptic plasticity. Biol Psychiatry 2014; 76: 927\u2013936.","journal-title":"Biol Psychiatry"},{"key":"BFmp201736_CR124","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0006-8993(87)90207-1","volume":"415","author":"TH Hand","year":"1987","unstructured":"Hand TH, Hu XT, Wang RY . Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons. Brain Res 1987; 415: 257\u2013269.","journal-title":"Brain Res"},{"key":"BFmp201736_CR125","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/sj.npp.1301087","volume":"32","author":"B Schilstr\u00f6m","year":"2007","unstructured":"Schilstr\u00f6m B, Ivanov VB, Wiker C, Svensson TH . Galantamine enhances dopaminergic neurotransmission in vivo via allosteric potentiation of nicotinic acetylcholine receptors. Neuropsychopharmacology 2007; 32: 43\u201353.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp201736_CR126","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S0278-5846(97)00043-2","volume":"21","author":"K Yoshida","year":"1997","unstructured":"Yoshida K, Higuchi H, Kamata M, Yoshimoto M, Shimizu T, Hishikawa Y . Dopamine releasing response in rat striatum to single and repeated electroconvulsive shock treatment. Prog Neuropsychopharmacol Biol Psychiatry 1997; 21: 707\u2013715.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFmp201736_CR127","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0306-4522(02)00652-8","volume":"117","author":"DS Lorrain","year":"2003","unstructured":"Lorrain DS, Baccei CS, Bristow LJ, Anderson JJ, Varney MA . Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268. Neuroscience 2003; 117: 697\u2013706.","journal-title":"Neuroscience"},{"key":"BFmp201736_CR128","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S0006-8993(02)03692-2","volume":"958","author":"J Ichikawa","year":"2002","unstructured":"Ichikawa J, Chung YC, Li Z, Dai J, Meltzer HY . Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens. Brain Res 2002; 958: 176\u2013184.","journal-title":"Brain Res"},{"key":"BFmp201736_CR129","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.brainres.2011.05.008","volume":"1399","author":"JC Zant","year":"2011","unstructured":"Zant JC, Leenaars CHC, Kostin A, Van Someren EJW, Porkka-Heiskanen T . Increases in extracellular serotonin and dopamine metabolite levels in the basal forebrain during sleep deprivation. Brain Res 2011; 1399: 40\u201348.","journal-title":"Brain Res"},{"key":"BFmp201736_CR130","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.psychres.2014.12.068","volume":"226","author":"J Luo","year":"2015","unstructured":"Luo J, Min S, Wei K, Cao J, Wang B, Li P et al. Behavioral and molecular responses to electroconvulsive shock differ between genetic and environmental rat models of depression. Psychiatry Res 2015; 226: 451\u2013460.","journal-title":"Psychiatry Res"},{"key":"BFmp201736_CR131","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.biopsych.2007.08.003","volume":"63","author":"KQ Tanis","year":"2008","unstructured":"Tanis KQ, Duman RS, Newton SS . CREB binding and activity in brain: regional specificity and induction by electroconvulsive seizure. Biol Psychiatry 2008; 63: 710\u2013720.","journal-title":"Biol Psychiatry"},{"key":"BFmp201736_CR132","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0028-3908(97)00047-6","volume":"36","author":"SH Jeon","year":"1997","unstructured":"Jeon SH, Seong YS, Juhnn YS, Kang UG, Ha KS, Kim YS et al. Electroconvulsive shock increases the phosphorylation of cyclic AMP response element binding protein at Ser-133 in rat hippocampus but not in cerebellum. Neuropharmacology 1997; 36: 411\u2013414.","journal-title":"Neuropharmacology"},{"key":"BFmp201736_CR133","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.eurpsy.2013.10.005","volume":"29","author":"W Zhou","year":"2014","unstructured":"Zhou W, Wang N, Yang C, Li X-M, Zhou Z-Q, Yang J-J . Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex. Eur Psychiatry 2014; 29: 419\u2013423.","journal-title":"Eur Psychiatry"},{"key":"BFmp201736_CR134","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3233\/JAD-130521","volume":"37","author":"Y-Y Wu","year":"2013","unstructured":"Wu Y-Y, Wang X, Tan L, Liu D, Liu X-H, Wang Q et al. Lithium attenuates scopolamine-induced memory deficits with inhibition of GSK-3\u03b2 and preservation of postsynaptic components. J Alzheimers Dis 2013; 37: 515\u2013527.","journal-title":"J Alzheimers Dis"},{"key":"BFmp201736_CR135","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.neulet.2016.10.017","volume":"635","author":"L Guo","year":"2016","unstructured":"Guo L, Guo Z, Luo X, Liang R, Yang S, Ren H et al. Phosphodiesterase 10A inhibition attenuates sleep deprivation-induced deficits in long-term fear memory. Neurosci Lett 2016; 635: 44\u201350.","journal-title":"Neurosci Lett"},{"key":"BFmp201736_CR136","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1089\/jmf.2015.3530","volume":"19","author":"X Su","year":"2016","unstructured":"Su X, Wang C, Wang X, Han F, Lv C, Zhang X . Sweet dream liquid chinese medicine ameliorates learning and memory deficit in a rat model of paradoxical sleep deprivation through the ERK\/CREB signaling pathway. J Med Food 2016; 19: 472\u2013480.","journal-title":"J Med Food"},{"key":"BFmp201736_CR137","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1113\/jphysiol.2006.115287","volume":"575","author":"R Guzman-Marin","year":"2006","unstructured":"Guzman-Marin R, Ying Z, Suntsova N, Methippara M, Bashir T, Szymusiak R et al. Suppression of hippocampal plasticity-related gene expression by sleep deprivation in rats. J Physiol 2006; 575: 807\u2013819.","journal-title":"J Physiol"},{"key":"BFmp201736_CR138","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.neuint.2015.07.023","volume":"89","author":"W Zhao","year":"2015","unstructured":"Zhao W, Wang J, Bi W, Ferruzzi M, Yemul S, Freire D et al. Novel application of brain-targeting polyphenol compounds in sleep deprivation-induced cognitive dysfunction. Neurochem Int 2015; 89: 191\u2013197.","journal-title":"Neurochem Int"},{"key":"BFmp201736_CR139","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.mcn.2015.12.015","volume":"71","author":"KA Alkadhi","year":"2016","unstructured":"Alkadhi KA, Alhaider IA . Caffeine and REM sleep deprivation: Effect on basal levels of signaling molecules in area CA1. Mol Cell Neurosci 2016; 71: 125\u2013131.","journal-title":"Mol Cell Neurosci"},{"key":"BFmp201736_CR140","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1111\/ejn.13092","volume":"42","author":"IA Alhaider","year":"2015","unstructured":"Alhaider IA, Alkadhi KA . Caffeine treatment prevents rapid eye movement sleep deprivation-induced impairment of late-phase long-term potentiation in the dentate gyrus. Eur J Neurosci 2015; 42: 2843\u20132850.","journal-title":"Eur J Neurosci"},{"key":"BFmp201736_CR141","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.bbr.2014.11.015","volume":"279","author":"I Azogu","year":"2015","unstructured":"Azogu I, de la Tremblaye PB, Dunbar M, Lebreton M, LeMarec N, Plamondon H . Acute sleep deprivation enhances avoidance learning and spatial memory and induces delayed alterations in neurochemical expression of GR, TH, DRD1, pCREB and Ki67 in rats. Behav Brain Res 2015; 279: 177\u2013190.","journal-title":"Behav Brain Res"},{"key":"BFmp201736_CR142","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/sj.mp.4000907","volume":"6","author":"B Vollmayr","year":"2001","unstructured":"Vollmayr B, Faust H, Lewicka S, Henn FA . Brain-derived-neurotrophic-factor (BDNF) stress response in rats bred for learned helplessness. Mol Psychiatry 2001; 6: 471\u2013474.","journal-title":"Mol Psychiatry"},{"key":"BFmp201736_CR143","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/sj.mp.4001897","volume":"12","author":"B Conti","year":"2007","unstructured":"Conti B, Maier R, Barr AM, Morale MC, Lu X, Sanna PP et al. Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine. Mol Psychiatry 2007; 12: 167\u2013189.","journal-title":"Mol Psychiatry"},{"key":"BFmp201736_CR144","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.brainres.2004.07.065","volume":"1024","author":"JPR Jacobsen","year":"2004","unstructured":"Jacobsen JPR, M\u00f8rk A . The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels. Brain Res 2004; 1024: 183\u2013192.","journal-title":"Brain Res"},{"key":"BFmp201736_CR145","doi-asserted-by":"publisher","first-page":"10841","DOI":"10.1523\/JNEUROSCI.23-34-10841.2003","volume":"23","author":"SS Newton","year":"2003","unstructured":"Newton SS, Collier EF, Hunsberger J, Adams D, Terwilliger R, Selvanayagam E et al. Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors. J Neurosci 2003; 23: 10841\u201310851.","journal-title":"J Neurosci"},{"key":"BFmp201736_CR146","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S0006-3223(03)00073-8","volume":"54","author":"CA Altar","year":"2003","unstructured":"Altar CA, Whitehead RE, Chen R, W\u00f6rtwein G, Madsen TM . Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biol Psychiatry 2003; 54: 703\u2013709.","journal-title":"Biol Psychiatry"},{"key":"BFmp201736_CR147","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.brs.2015.10.009","volume":"9","author":"H Moshe","year":"2016","unstructured":"Moshe H, Gal R, Barnea-Ygael N, Gulevsky T, Alyagon U, Zangen A . Prelimbic stimulation ameliorates depressive-like behaviors and increases regional BDNF expression in a novel drug-resistant animal model of depression. Brain Stimul 2016; 9: 243\u2013250.","journal-title":"Brain Stimul"},{"key":"BFmp201736_CR148","first-page":"269","volume":"65","author":"N Hidaka","year":"2011","unstructured":"Hidaka N, Suemaru K, Takechi K, Li B, Araki H . Inhibitory effects of valproate on impairment of Y-maze alternation behavior induced by repeated electroconvulsive seizures and c-Fos protein levels in rat brains. Acta Med Okayama 2011; 65: 269\u2013277.","journal-title":"Acta Med Okayama"},{"key":"BFmp201736_CR149","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1055\/s-0029-1224162","volume":"42","author":"A Sartorius","year":"2009","unstructured":"Sartorius A, Hellweg R, Litzke J, Vogt M, Dormann C, Vollmayr B et al. Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats. Pharmacopsychiatry 2009; 42: 270\u2013276.","journal-title":"Pharmacopsychiatry"},{"key":"BFmp201736_CR150","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.biopsych.2012.07.025","volume":"74","author":"D Taliaz","year":"2013","unstructured":"Taliaz D, Nagaraj V, Haramati S, Chen A, Zangen A . Altered brain-derived neurotrophic factor expression in the ventral tegmental area, but not in the hippocampus, is essential for antidepressant-like effects of electroconvulsive therapy. Biol Psychiatry 2013; 74: 305\u2013312.","journal-title":"Biol Psychiatry"},{"key":"BFmp201736_CR151","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.psychres.2011.09.010","volume":"198","author":"J Luo","year":"2012","unstructured":"Luo J, Min S, Wei K, Zhang J, Liu Y . Propofol interacts with stimulus intensities of electroconvulsive shock to regulate behavior and hippocampal BDNF in a rat model of depression. Psychiatry Res 2012; 198: 300\u2013306.","journal-title":"Psychiatry Res"},{"key":"BFmp201736_CR152","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.pnpbp.2011.12.012","volume":"37","author":"S O\u2019Donovan","year":"2012","unstructured":"O\u2019Donovan S, Kennedy M, Guinan B, O\u2019Mara S, McLoughlin DM . A comparison of brief pulse and ultrabrief pulse electroconvulsive stimulation on rodent brain and behaviour. Prog Neuropsychopharmacol Biol Psychiatry 2012; 37: 147\u2013152.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFmp201736_CR153","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.biopsych.2009.09.015","volume":"67","author":"R Gersner","year":"2010","unstructured":"Gersner R, Toth E, Isserles M, Zangen A . Site-specific antidepressant effects of repeated subconvulsive electrical stimulation: potential role of brain-derived neurotrophic factor. Biol Psychiatry 2010; 67: 125\u2013132.","journal-title":"Biol Psychiatry"},{"key":"BFmp201736_CR154","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.brainres.2008.03.023","volume":"1211","author":"DT Balu","year":"2008","unstructured":"Balu DT, Hoshaw BA, Malberg JE, Rosenzweig-Lipson S, Schechter LE, Lucki I . Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments. Brain Res 2008; 1211: 37\u201343.","journal-title":"Brain Res"},{"key":"BFmp201736_CR155","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/j.lfs.2007.01.032","volume":"80","author":"B Li","year":"2007","unstructured":"Li B, Suemaru K, Cui R, Araki H . Repeated electroconvulsive stimuli have long-lasting effects on hippocampal BDNF and decrease immobility time in the rat forced swim test. Life Sci 2007; 80: 1539\u20131543.","journal-title":"Life Sci"},{"key":"BFmp201736_CR156","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/00124509-200209000-00005","volume":"18","author":"F Angelucci","year":"2002","unstructured":"Angelucci F, Aloe L, Jim\u00e9nez-Vasquez P, Math\u00e9 AA . Electroconvulsive stimuli alter the regional concentrations of nerve growth factor, brain-derived neurotrophic factor, and glial cell line-derived neurotrophic factor in adult rat brain. J ECT 2002; 18: 138\u2013143.","journal-title":"J ECT"},{"key":"BFmp201736_CR157","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/00124509-200103000-00006","volume":"17","author":"AC Chen","year":"2001","unstructured":"Chen AC, Shin KH, Duman RS, Sanacora G . ECS-Induced mossy fiber sprouting and BDNF expression are attenuated by ketamine pretreatment. J ECT 2001; 17: 27\u201332.","journal-title":"J ECT"},{"key":"BFmp201736_CR158","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S0169-328X(98)00077-1","volume":"57","author":"TS Zetterstr\u00f6m","year":"1998","unstructured":"Zetterstr\u00f6m TS, Pei Q, Grahame-Smith DG . Repeated electroconvulsive shock extends the duration of enhanced gene expression for BDNF in rat brain compared with a single administration. Brain Res Mol Brain Res 1998; 57: 106\u2013110.","journal-title":"Brain Res Mol Brain Res"},{"key":"BFmp201736_CR159","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/0306-4522(94)00550-O","volume":"65","author":"N Lindefors","year":"1995","unstructured":"Lindefors N, Brodin E, Metsis M . Spatiotemporal selective effects on brain-derived neurotrophic factor and trkB messenger RNA in rat hippocampus by electroconvulsive shock. Neuroscience 1995; 65: 661\u2013670.","journal-title":"Neuroscience"},{"key":"BFmp201736_CR160","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.psychres.2006.05.020","volume":"145","author":"UG Kang","year":"2006","unstructured":"Kang UG, Koo YJ, Jeon WJ, Park DB, Juhnn YS, Park JB et al. Activation of extracellular signal-regulated kinase signaling by chronic electroconvulsive shock in the rat frontal cortex. Psychiatry Res 2006; 145: 75\u201378.","journal-title":"Psychiatry Res"},{"key":"BFmp201736_CR161","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.gene.2014.01.072","volume":"539","author":"M Dyrvig","year":"2014","unstructured":"Dyrvig M, Christiansen SH, Woldbye DPD, Lichota J . Temporal gene expression profile after acute electroconvulsive stimulation in the rat. Gene 2014; 539: 8\u201314.","journal-title":"Gene"},{"key":"BFmp201736_CR162","first-page":"761238","volume":"2015","author":"H Zhang","year":"2015","unstructured":"Zhang H, Xue W, Wu R, Gong T, Tao W, Zhou X et al. Rapid antidepressant activity of ethanol extract of gardenia jasminoides ellis is associated with upregulation of BDNF expression in the hippocampus. Evid Based Complement Altern Med 2015; 2015: 761238.","journal-title":"Evid Based Complement Altern Med"},{"key":"BFmp201736_CR163","doi-asserted-by":"publisher","first-page":"256","DOI":"10.2174\/157340608784325124","volume":"4","author":"A Becker","year":"2008","unstructured":"Becker A, Grecksch G, Schwegler H, Roskoden T . Expression of mRNA of neurotrophic factors and their receptors are significantly altered after subchronic ketamine treatment. Med Chem 2008; 4: 256\u2013263.","journal-title":"Med Chem"},{"key":"BFmp201736_CR164","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1385\/JMN:21:3:223","volume":"21","author":"H Fujihara","year":"2003","unstructured":"Fujihara H, Sei H, Morita Y, Ueta Y, Morita K . Short-term sleep disturbance enhances brain-derived neurotrophic factor gene expression in rat hippocampus by acting as internal stressor. J Mol Neurosci 2003; 21: 223\u2013232.","journal-title":"J Mol Neurosci"},{"key":"BFmp201736_CR165","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s10571-007-9145-1","volume":"27","author":"HH Hansen","year":"2007","unstructured":"Hansen HH, Rantam\u00e4ki TPJ, Larsen MH, Woldbye DPD, Mikkelsen JD, Castr\u00e9n EH . Rapid activation of the extracellular signal-regulated kinase 1\/2 (ERK1\/2) signaling pathway by electroconvulsive shock in the rat prefrontal cortex is not associated with TrkB neurotrophin receptor activation. Cell Mol Neurobiol 2007; 27: 585\u2013594.","journal-title":"Cell Mol Neurobiol"},{"key":"BFmp201736_CR166","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1038\/npp.2013.128","volume":"38","author":"R-J Liu","year":"2013","unstructured":"Liu R-J, Fuchikami M, Dwyer JM, Lepack AE, Duman RS, Aghajanian GK . GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine. Neuropsychopharmacology 2013; 38: 2268\u20132277.","journal-title":"Neuropsychopharmacology"},{"key":"BFmp201736_CR167","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/j.neuropharm.2011.12.031","volume":"62","author":"M Moosavi","year":"2012","unstructured":"Moosavi M, Khales GY, Abbasi L, Zarifkar A, Rastegar K . Agmatine protects against scopolamine-induced water maze performance impairment and hippocampal ERK and Akt inactivation. Neuropharmacology 2012; 62: 2018\u20132023.","journal-title":"Neuropharmacology"},{"key":"BFmp201736_CR168","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1093\/sleep\/32.2.227","volume":"32","author":"P Ravassard","year":"2009","unstructured":"Ravassard P, Pachoud B, Comte J-C, Mejia-Perez C, Scot\u00e9-Blachon C, Gay N et al. Paradoxical (REM) sleep deprivation causes a large and rapidly reversible decrease in long-term potentiation, synaptic transmission, glutamate receptor protein levels, and ERK\/MAPK activation in the dorsal hippocampus. Sleep 2009; 32: 227\u2013240.","journal-title":"Sleep"},{"key":"BFmp201736_CR169","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.expneurol.2010.07.010","volume":"225","author":"M Fujiki","year":"2010","unstructured":"Fujiki M, Abe E, Nagai Y, Shiqi K, Kubo T, Ishii K et al. Electroconvulsive seizure-induced VEGF is correlated with neuroprotective effects against cerebral infarction: involvement of the phosphatidylinositol-3 kinase\/Akt pathway. Exp Neurol 2010; 225: 377\u2013383.","journal-title":"Exp Neurol"},{"key":"BFmp201736_CR170","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0278-5846(03)00173-8","volume":"28","author":"UG Kang","year":"2004","unstructured":"Kang UG, Roh M-S, Jung J-R, Shin SY, Lee YH, Park J-B et al. Activation of protein kinase B (Akt) signaling after electroconvulsive shock in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 41\u201344.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFmp201736_CR171","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.nbd.2015.06.012","volume":"82","author":"A Navarria","year":"2015","unstructured":"Navarria A, Wohleb ES, Voleti B, Ota KT, Dutheil S, Lepack AE et al. Rapid antidepressant actions of scopolamine: role of medial prefrontal cortex and M1-subtype muscarinic acetylcholine receptors. Neurobiol Dis 2015; 82: 254\u2013261.","journal-title":"Neurobiol Dis"},{"key":"BFmp201736_CR172","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/YCT.0b013e318290f7ff","volume":"29","author":"K Basar","year":"2013","unstructured":"Basar K, Eren-Kocak E, Ozdemir H, Ertugrul A . Effects of acute and chronic electroconvulsive shocks on glycogen synthase kinase 3\u03b2 level and phosphorylation in mice. J ECT. 2013; 29: 265\u2013270.","journal-title":"J ECT."},{"key":"BFmp201736_CR173","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0278-5846(02)00307-X","volume":"27","author":"M-S Roh","year":"2003","unstructured":"Roh M-S, Kang UG, Shin SY, Lee YH, Jung HY, Juhnn Y-S et al. Biphasic changes in the Ser-9 phosphorylation of glycogen synthase kinase-3beta after electroconvulsive shock in the rat brain. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 1\u20135.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFmp201736_CR174","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.bbr.2012.08.008","volume":"235","author":"J Gr\u00f8nli","year":"2012","unstructured":"Gr\u00f8nli J, Dagestad G, Milde AM, Murison R, Bramham CR . Post-transcriptional effects and interactions between chronic mild stress and acute sleep deprivation: regulation of translation factor and cytoplasmic polyadenylation element-binding protein phosphorylation. Behav Brain Res 2012; 235: 251\u2013262.","journal-title":"Behav Brain Res"},{"key":"BFmp201736_CR175","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","volume":"17","author":"B Moghaddam","year":"1997","unstructured":"Moghaddam B, Adams B, Verma A, Daly D . Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 1997; 17: 2921\u20132927.","journal-title":"J Neurosci"},{"key":"BFmp201736_CR176","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/mp.2016.34","volume":"22","author":"GMI Chowdhury","year":"2016","unstructured":"Chowdhury GMI, Zhang J, Thomas M, Banasr M, Ma X, Pittman B et al. Transiently increased glutamate cycling in rat PFC is associated with rapid onset of antidepressant-like effects. Mol Psychiatry 2016; 22: 120\u2013126.","journal-title":"Mol Psychiatry"},{"key":"BFmp201736_CR177","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1080\/01616412.2015.1114231","volume":"37","author":"F Xie","year":"2015","unstructured":"Xie F, Li X, Bao M, Shi R, Yue Y, Guan Y et al. Anesthetic propofol normalized the increased release of glutamate and \u03b3-amino butyric acid in hippocampus after paradoxical sleep deprivation in rats. Neurol Res 2015; 37: 1102\u20131107.","journal-title":"Neurol Res"},{"key":"BFmp201736_CR178","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/syn.20538","volume":"62","author":"B Elfving","year":"2008","unstructured":"Elfving B, Bonefeld BE, Rosenberg R, Wegener G . Differential expression of synaptic vesicle proteins after repeated electroconvulsive seizures in rat frontal cortex and hippocampus. Synapse 2008; 62: 662\u2013670.","journal-title":"Synapse"},{"key":"BFmp201736_CR179","first-page":"1847","volume":"10","author":"J Luo","year":"2014","unstructured":"Luo J, Min S, Wei K, Cao J, Wang B, Li P et al. Propofol prevents electroconvulsive-shock-induced memory impairment through regulation of hippocampal synaptic plasticity in a rat model of depression. Neuropsychiatr Dis Treat 2014; 10: 1847\u20131859.","journal-title":"Neuropsychiatr Dis Treat"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/mp201736.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/mp201736","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/mp.2017.36","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/mp201736.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:44:56Z","timestamp":1648781096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/mp201736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,21]]},"references-count":179,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["BFmp201736"],"URL":"https:\/\/doi.org\/10.1038\/mp.2017.36","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,21]]},"assertion":[{"value":"18 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}